These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33630017)

  • 41. Safe drugs and the cost of good intentions.
    Eichler HG; Abadie E; Raine JM; Salmonson T
    N Engl J Med; 2009 Apr; 360(14):1378-80. PubMed ID: 19339718
    [No Abstract]   [Full Text] [Related]  

  • 42. The FDA and the pharmaceutical industry: is regulation contributing to drug shortage?
    Roman A
    Albany Law Rev; 2013-2014; 77(2):539-77. PubMed ID: 24851322
    [No Abstract]   [Full Text] [Related]  

  • 43. The reimbursement factor in pharmaceutical regulation: rebates, cost-effectiveness, and practice guidelines.
    Shulman SR
    Pharmacoeconomics; 1992; 1(Suppl 1):21-7. PubMed ID: 10146927
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Coding and medicare payment for discarded drugs and biologicals.
    Schaum KD
    Adv Skin Wound Care; 2010 Sep; 23(9):398-403. PubMed ID: 20729644
    [No Abstract]   [Full Text] [Related]  

  • 45. To ban or not to ban--that is the question: the constitutionality of a moratorium on consumer drug advertising.
    Schwartz MI
    Food Drug Law J; 2008; 63(1):1-33. PubMed ID: 18561453
    [No Abstract]   [Full Text] [Related]  

  • 46. Evolution of recombinant human erythropoietin usage in clinical practice in the United States. Is there an optimal way to use rHuEPO?
    Besarab A; McCrea JB
    ASAIO J; 1993; 39(1):11-8. PubMed ID: 8439674
    [No Abstract]   [Full Text] [Related]  

  • 47. Comparing patient access to pharmaceuticals in the UK and US.
    Cohen J; Cairns C; Paquette C; Faden L
    Appl Health Econ Health Policy; 2006; 5(3):177-87. PubMed ID: 17132032
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Individual patient treatment use of unapproved drugs: a new option for the seriously ill.
    Simon LS; Green A
    J Pain Palliat Care Pharmacother; 2010 Mar; 24(1):19-22. PubMed ID: 20345195
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Measuring the Value of New Medications and Implications for Medicare's Proposed Part B Drug Payment Model.
    Hwang TJ; LaMattina JL
    JAMA Oncol; 2016 Sep; 2(9):1125-6. PubMed ID: 27388928
    [No Abstract]   [Full Text] [Related]  

  • 50. Drug prices: real problem, wrong solution.
    Kennedy D
    Science; 2001 Jun; 292(5523):1797. PubMed ID: 11397914
    [No Abstract]   [Full Text] [Related]  

  • 51. Drugs, codes, standards, and other incompatible things in the dark.
    Chute CG
    MD Comput; 2001; 18(1):45-6. PubMed ID: 11236386
    [No Abstract]   [Full Text] [Related]  

  • 52. Estimated cost savings associated with the transfer of office-administered specialty pharmaceuticals to a specialty pharmacy provider in a Medical Injectable Drug program.
    Baldini CG; Culley EJ
    J Manag Care Pharm; 2011; 17(1):51-9. PubMed ID: 21204590
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ASHP statement on hospital drug control systems.
    Am J Hosp Pharm; 1974 Dec; 31(12):1198-207. PubMed ID: 4458439
    [No Abstract]   [Full Text] [Related]  

  • 54. Local governments in US buy cheaper prescription drugs from Canada.
    Hopkins Tanne J
    BMJ; 2003 Nov; 327(7424):1126. PubMed ID: 14615317
    [No Abstract]   [Full Text] [Related]  

  • 55. Pharmaceuticals and medical devices: cost savings. Issue brief.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Dec; ():1-33. PubMed ID: 23297446
    [No Abstract]   [Full Text] [Related]  

  • 56. [Orphan drugs].
    Galeffi C
    Ann Ist Super Sanita; 1991; 27(2):341-3. PubMed ID: 1661568
    [TBL] [Abstract][Full Text] [Related]  

  • 57. AMCP Partnership Forum: Designing Benefits and Payment Models for Innovative High-Investment Medications.
    J Manag Care Spec Pharm; 2019 Feb; 25(2):156-162. PubMed ID: 30698091
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmaceuticals and medical devices: business practices.
    ; Steiner DJ
    Issue Brief Health Policy Track Serv; 2014 Dec; ():1-38. PubMed ID: 25771555
    [No Abstract]   [Full Text] [Related]  

  • 59. Prescriptions imported into the United States.
    Tenn Med; 2004 Aug; 97(8):337. PubMed ID: 15376708
    [No Abstract]   [Full Text] [Related]  

  • 60. Pharmaceuticals: Medicare Modernization Act.
    Hilyard K; Howe WC
    Issue Brief Health Policy Track Serv; 2007 Jan; ():1-28. PubMed ID: 17361467
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.